Order Article Reprints

Zattoni F, Mari A, Falagario UG, Bertolo RG, Albisinni S, Amparore D, Bianchi L, Campi R, Contieri R, De Lorenzis E, et al. Beyond One-Size-Fits-All Active Surveillance for Low-Risk Prostate Cancer: Risk-Adapted Follow-Up, De-Escalation Pathways, and Focal Therapy as Tailored Strategy. Diagnostics. 2026; 16(9):1310. https://doi.org/10.3390/diagnostics16091310

Zattoni, Fabio, Andrea Mari, Ugo Giovanni Falagario, Riccardo Giuseppe Bertolo, Simone Albisinni, Daniele Amparore, Lorenzo Bianchi, Riccardo Campi, Roberto Contieri, Elisa De Lorenzis, and et al. 2026. "Beyond One-Size-Fits-All Active Surveillance for Low-Risk Prostate Cancer: Risk-Adapted Follow-Up, De-Escalation Pathways, and Focal Therapy as Tailored Strategy" Diagnostics 16, no. 9: 1310. https://doi.org/10.3390/diagnostics16091310

Zattoni, F., Mari, A., Falagario, U. G., Bertolo, R. G., Albisinni, S., Amparore, D., Bianchi, L., Campi, R., Contieri, R., De Lorenzis, E., Dell’Oglio, P., Marchioni, M., Mollica, V., Moschini, M., Soria, F., Talso, M., Turri, F., & Pandolfo, S. D., the Uronauti Group. (2026). Beyond One-Size-Fits-All Active Surveillance for Low-Risk Prostate Cancer: Risk-Adapted Follow-Up, De-Escalation Pathways, and Focal Therapy as Tailored Strategy. Diagnostics, 16(9), 1310. https://doi.org/10.3390/diagnostics16091310